- Home
- ANTX vs DOUG Comparison
ANTX vs DOUG Comparison
Compare ANTX & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANTX | DOUG |
|---|---|---|
| Founded | 2017 | 1911 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 178.2M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ANTX | DOUG |
|---|---|---|
| Price | $5.83 | $1.92 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | 196.2K | ★ 329.2K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.56 | ★ 118.68 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $955,578,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $1.53 |
| 52 Week High | $7.19 | $3.19 |
Technical Indicators
Market Signals| Indicator | ANTX | DOUG |
|---|---|---|
| Relative Strength Index (RSI) | 58.96 | 54.97 |
| Support Level | $3.91 | $1.70 |
| Resistance Level | $6.91 | $2.05 |
| Average True Range (ATR) | 0.49 | 0.09 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 38.43 | 51.65 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.